NTRS vs SNOA · P/E 18, rev $2.69B vs rev $19.5M
Northern Trust Corporation (NTRS) versus Sonoma Pharmaceuticals Inc (SNOA) — a side-by-side from cached financials, not a winner call.
Northern Trust Corporation (NTRS) is a asset management company listed on US.
Sonoma Pharmaceuticals Inc (SNOA) is a drug manufacturers - specialty & generic company listed on US.
Latest reported NTRS revenue for 2026-06-30 was $2.69B. Net income was $1.32B. NTRS currently screens at market cap $32.02B and trailing P/E 18.1.
Latest reported SNOA revenue for 2026-03-31 was $19.5M. Net income was -$3.2M. Revenue was up 36.7% from 2025-03-31 to 2026-03-31. SNOA currently screens at market cap $4.9M.
NTRS currently screens at market cap $32.02B and trailing P/E 18.1. SNOA currently screens at market cap $4.9M.
Not investment advice. Open the NTRS and SNOA stock pages for the full models.
Not investment advice.